Millennium Management
CUE icon

Millennium Management’s Cue Biopharma CUE Stock Holding History

Millennium Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,310
Closed -$75.5K – 5952
2024
Q4 		$75.5K Sell
2,310
-9,656
-81% -$363K ﹤0.01% 5526
2024
Q3 		$272K Sell
11,966
-4,500
-27% -$97.5K ﹤0.01% 5262
2024
Q2 		$613K Buy
16,466
+4,396
+36% +$217K ﹤0.01% 4460
2024
Q1 		$684K Buy
12,070
+2,882
+31% +$203K ﹤0.01% 4596
2023
Q4 		$728K Sell
9,188
-1,278
-12% -$91.4K ﹤0.01% 4395
2023
Q3 		$722K Buy
10,466
+4,538
+77% +$443K ﹤0.01% 4420
2023
Q2 		$649K Sell
5,928
-5,559
-48% -$653K ﹤0.01% 4361
2023
Q1 		$1.23M Sell
11,487
-979
-8% -$93.4K ﹤0.01% 3900
2022
Q4 		$1.07M Sell
12,466
-2,213
-15% -$202K ﹤0.01% 4101
2022
Q3 		$982K Sell
14,679
-5,395
-27% -$464K ﹤0.01% 4362
2022
Q2 		$1.5M Buy
20,074
+16,058
+400% +$1.88M ﹤0.01% 3994
2022
Q1 		$588K Buy
4,016
+209
+5% +$44.3K ﹤0.01% 5000
2021
Q4 		$1.29M Buy
3,807
+1,055
+38% +$408K ﹤0.01% 4166
2021
Q3 		$1.2M Sell
2,752
-4,892
-64% -$1.71M ﹤0.01% 4477
2021
Q2 		$2.67M Buy
7,644
+5,031
+193% +$1.95M ﹤0.01% 3595
2021
Q1 		$956K Sell
2,613
-9,471
-78% -$3.9M ﹤0.01% 4260
2020
Q4 		$4.54M Buy
12,084
+6,068
+101% +$2.42M ﹤0.01% 2545
2020
Q3 		$2.72K Sell
6,016
-1,370
-19% -$789K ﹤0.01% 2360
2020
Q2 		$5.43M Buy
+7,386
New +$5.35M 0.01% 1692
2019
Q4 		– Sell
-464
Closed -$117K – 4274
2019
Q3 		$117K Buy
+464
New +$111K ﹤0.01% 3937
2019
Q2 		– Sell
-370
Closed -$86K – 4103
2019
Q1 		$86K Buy
+370
New +$70.4K ﹤0.01% 3860

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management's CUE Position: Q1 2025 in Review

Millennium Management sold out of Cue Biopharma (CUE) in Q1 2025, closing a stake of 2,310 shares — an estimated $75.5K sold.

Millennium Management first reported a position in CUE in Q1 2019 and held it in 21 quarters. The position peaked at $5.43M in Q2 2020. 49 funds tracked by Wall St. Rank hold CUE as of Q1 2025.

  • Millennium Management reported no remaining Cue Biopharma position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 2,310 Cue Biopharma shares in Q1 2025, an estimated $75.5K.
  • Millennium Management first reported a position in Cue Biopharma in Q1 2019 and held it in 21 quarters.
  • Millennium Management's Cue Biopharma position peaked at $5.43M in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.